Abstract
IntroductionFirst trimester combined fetal aneuploidy screening is the most widely implemented model at national level. Although it is well established to perform quality control of biochemical measurements, it has been seldom applied to ultrasound measures.The aim of this paper is to describe how to implement a model of quality control in the laboratory, which includes all markers in prenatal screening for aneuploidy. MethodsWe have evaluated the precision and bias of biochemical markers. In the case of nuchal translucency (NT), the WIHRI method was employed to control quality, and CUSUM was applied to each ultrasound operator with the values extracted from the computer software database. ResultsFor the biochemical parameters CV was below 4%. The bias was within the specification for the analyte concentration levels, as was the case for MoMs, except for one month. Quality control of NT showed that 5 of the 8 ultrasound operators evaluated sdid not comply with the quality criteria when using the WIHRI method, and 6 when CUSUM was applied. ConclusionsAfter showing the difficulty in obtaining accurate NT measurements to the professionals involved, it was possible to reach a consensus on using the CUSUM method for quality control of NT. In this way, the laboratory will be responsible for sending a report to each ultrasound operatorin the cases where the deviation exceeds the established limit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
